Skip to main content
OpenTrials
Completed

NCT Number: NCT01981954

A Clinical Study to Investigate How Solifenacin Fluid is Taken up, How Long it Stays in the Body and How Effective and Safe it is in Treating Children Aged From 6 Months to Less Than 5 Years With Symptoms of Neurogenic Detrusor Overactivity (NDO)

The purpose of this study was to evaluate long term efficacy and safety of treatment with solifenacin succinate (the study drug) in children with neurogenic detrusor overactivity after multiple dose administration.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–4 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Site BE3203 Gent University Hospital, Ghent, Belgium

Loading trial locations.

About this study

In some children with a severe form of spina bifida (which is the consequence of a spinal cord defect), the bladder muscle (detrusor) contracts strongly and without warning (also known as neurogenic detrusor overactivity) and the urethra (the passage connecting the bladder with outside) does not relax. Though these children cannot void, urine leakage can happen when the overactive contractions are strong, and/or the pressure in the bladder is so high that it overcomes the closed urethra (overflow at high filling bladder pressure). This high bladder pressure puts these children at risk for kidney damage and can decrease the quality of the bladder. Therapy was aimed to decrease the high filling bladder pressure and the overactive detrusor contractions.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Myelomeningocoele
  • Documented diagnosis of NDO, confirmed by urodynamics
  • DSD (detrusor sphincter dyssynergia)
  • Practicing clean intermittent catheterization (CIC)

Exclusion criteria

  • Know genitourinary condition (other than NDO) that may cause incontinence
  • Bladder augmentation surgery
  • Current faecal impaction
  • Electro-stimulation therapy within 2 weeks prior to visit
  • Subjects with the following gastro-intestinal problems: partial or complete obstructions, decreased motility like paralytic ileus, subjects at risk of gastric retention
  • Reflux grade 3 to 5
  • Current urinary tract infection

Treatment and study plan

Solifenacin succinate

Drug

Oral suspension

Other names: solifenacin, YM905, solifenacin succinate suspension

Primary outcomes

  1. Change From Baseline to Week 24 in Maximum Cystometric Capacity (MCC)

    Time frame: Baseline and Week 24

    MCC was the volume instilled into the bladder prior to leakage or end of bladder-filling (whichever was reached first), as assessed by urodynamics (procedure: the bladder was to be filled until voiding/leakage began, or until it was stopped because either the participant experienced pain or discomfort or 135% of expected bladder capacity [EBC] was reached for participants ≥ 2 years or of maximum catheterized volume [MCV] for participants aged 6 months to < 2 years; the participants' bladder was emptied via catheterization).

Secondary outcomes

  1. Change From Baseline to Weeks 3, 6, 9, 12 and 52 in MCC

    Time frame: Baseline and Weeks 3, 6, 9, 12, 52

    MCC was the volume instilled into the bladder prior to leakage or end of bladder-filling (whichever was reached first) as assessed by urodynamics (procedure: the bladder was to be filled until voiding/leakage began, or until it was stopped because either the participant experienced pain or discomfort or 135% of EBC was reached for participants ≥ 2 years or of MCV for participants aged 6 months to < 2 years. The participants' bladder was emptied via catheterization).

  2. Change From Baseline to Weeks 3, 6, 9, 12, 24 and 52 in Bladder Compliance

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 52

    Bladder compliance gives an indication of the elasticity of the bladder wall. Bladder compliance was calculated by dividing the change in volume during the filling of the bladder by the change in detrusor pressure during that change in bladder volume using urodynamic assessments. The values for bladder volume and detrusor pressure at the beginning and end of filling were taken and used.

  3. Change From Baseline to Weeks 3, 6, 9, 12, 24 and 52 in Detrusor Pressure at End of Bladder-Filling

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 52

    Detrusor pressure was expressed as bladder pressure minus intra-abdominal pressure as assessed by urodynamics.

  4. Change From Baseline to Weeks 3, 6, 9, 12, 24 and 52 in Detrusor Pressure 5 Minutes After End of Bladder-Filling

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 52

    Detrusor pressure was expressed as bladder pressure minus intra-abdominal pressure as assessed by urodynamics.

  5. Change From Baseline to Weeks 3, 6, 9, 12, 24 and 52 in Catheterized Volume 5 Minutes After End of Bladder-Filling

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 52

    Catheterized volume was measured when the bladder was emptied via catheterization 5 minutes after the end of bladder-filling.

  6. Change From Baseline to Weeks 3, 6, 9, 12, 24 and 52 in Bladder Volume Until First Detrusor Contraction (> 15 cmH2O)

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 52

    Bladder volume as assessed by urodynamics.

  7. Change From Baseline to Weeks 3, 6, 9, 12, 24 and 52 in Bladder Volume at 10 cmH20 Detrusor Pressure

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 52

    Bladder volume as assessed by urodynamics.

  8. Change From Baseline to Weeks 3, 6, 9, 12, 24 and 52 in Bladder Volume at 20 cmH20 Detrusor Pressure

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 52

    Bladder volume as assessed by urodynamics.

  9. Change From Baseline to Weeks 3, 6, 9, 12, 24 and 52 in Bladder Volume at 30 cmH20 Detrusor Pressure

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 52

    Bladder volume as assessed by urodynamics.

  10. Change From Baseline to Weeks 3, 6, 9, 12, 24 and 52 in Number of Overactive Detrusor Contractions (> 15 cmH2O) Until Leakage or End of Bladder-Filling

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 52

  11. Change From Baseline to Weeks 3, 6, 9, 12, 24, 36 and 52 in Average Catheterized Volume Per Catheterization

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 36, 52

    The average catheterized volume per catheterization was calculated using all available (non-zero) catheterized volumes recorded over both of the 2 measuring days in the diary, whether or not these 2 days were concurrent. Catheterized volumes were recorded for 2 days in a participant diary prior to each visit. Four to six catheterizations were performed every day.

  12. Change From Baseline to Weeks 3, 6, 9, 12, 24, 36 and 52 in Maximum Catheterized Volume (MCV)

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 36, 52

    The maximum catheterized volume per day was calculated using all available (non-zero) catheterized volumes recorded for the 2 measuring days in the diary, whether or not these 2 days were concurrent. The maximum value was calculated separately for each measuring day and the mean of these two values was used.

  13. Change From Baseline to Weeks 3, 6, 9, 12, 24, 36 and 52 in Average First Morning Catheterized Volume

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 36, 52

    The first morning catheterized volume was the volume associated with the first morning catheterization. The average first morning catheterized volume was calculated as the average of the available first morning catheterized volumes recorded for the 2 measuring days in the diary, whether or not these 2 days are concurrent.

  14. Change From Baseline to Weeks 3, 6, 9, 12, 24, 36 and 52 in Mean Number of Periods Between the Clean Intermittent Catheterizations (CICs) With Incontinence Per 24 Hours

    Time frame: Baseline and Weeks 3, 6, 9, 12, 24, 36, 52

    Participants were required to have 4-6 CICs per day on a schedule fixed for the duration of the study. To calculate the number of periods between CICs with incontinence in a diary day, the diary day was divided into periods between CICs (i.e. inter-CIC periods). The hour period, rather than the exact time, of each CIC and incontinence episode was recorded in the diary. When an incontinence episode and a CIC were marked in the same hour period, the incontinence episode was counted as occurring prior to the CIC (when the bladder had not yet emptied), rather than after it (when the bladder had recently been emptied), i.e. the inter-CIC period ended with the hour in which the CIC was recorded. The mean number of periods between CICs with incontinence per 24 hours was the number of periods between CICs when incontinence occurred, divided by the total number of valid diary days.

  15. Percentage of Days With Catheterizations for Each Hour of 24 Hour Day at Baseline

    Time frame: 3 days prior to Baseline visit

    For each one hour period of the 24 hour day, the percentage of days with catheterization was assessed as the number of days with catheterization occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  16. Percentage of Days With Catheterizations for Each Hour of 24 Hour Day During Week 3

    Time frame: 3 days prior to Week 3 visit

    For each one hour period of the 24 hour day, the percentage of days with catheterization was assessed as the number of days with catheterization occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  17. Percentage of Days With Catheterizations for Each Hour of 24 Hour Day During Week 6

    Time frame: 3 days prior to Week 6 visit

    For each one hour period of the 24 hour day, the percentage of days with catheterization was assessed as the number of days with catheterization occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  18. Percentage of Days With Catheterizations for Each Hour of 24 Hour Day During Week 9

    Time frame: 3 days prior to Week 9 visit

    For each one hour period of the 24 hour day, the percentage of days with catheterization was assessed as the number of days with catheterization occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  19. Percentage of Days With Catheterizations for Each Hour of 24 Hour Day During Week 12

    Time frame: 3 days prior to Week 12 visit

    For each one hour period of the 24 hour day, the percentage of days with catheterization was assessed as the number of days with catheterization occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  20. Percentage of Days With Catheterizations for Each Hour of 24 Hour Day During Week 24

    Time frame: 3 days prior to Week 24 visit

    For each one hour period of the 24 hour day, the percentage of days with catheterization was assessed as the number of days with catheterization occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  21. Percentage of Days With Catheterizations for Each Hour of 24 Hour Day During Week 36

    Time frame: 3 days prior to Week 36 visit

    For each one hour period of the 24 hour day, the percentage of days with catheterization was assessed as the number of days with catheterization occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  22. Percentage of Days With Catheterizations for Each Hour of 24 Hour Day During Week 52

    Time frame: 3 days prior to Week 52 visit

    For each one hour period of the 24 hour day, the percentage of days with catheterization was assessed as the number of days with catheterization occurring within the one hour period divided by the number of valid diary days over all subjects. Each participant contributed to up to three days of valid diary data for each visit.

  23. Percentage of Days With Incontinence for Each Hour of 24 Hour Day at Baseline

    Time frame: 3 days prior to Baseline visit

    Incontinence was defined as leakage where a diaper is not used, or dampness where a diaper is used. For each one hour period of the 24 hour day, the percentage of days with incontinence was assessed as the number of days with incontinence occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  24. Percentage of Days With of Incontinence for Each Hour of 24 Hour Day During Week 3

    Time frame: 3 days prior to Week 3 visit

    Incontinence was defined as leakage where a diaper is not used, or dampness where a diaper is used. For each one hour period of the 24 hour day, the percentage of days with incontinence was assessed as the number of days with incontinence occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  25. Percentage of Days With Incontinence for Each Hour of 24 Hour Day During Week 6

    Time frame: 3 days prior to Week 6 visit

    Incontinence was defined as leakage where a diaper is not used, or dampness where a diaper is used. For each one hour period of the 24 hour day, the percentage of days with incontinence was assessed as the number of days with incontinence occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  26. Percentage of Days With Incontinence for Each Hour of 24 Hour Day During Week 9

    Time frame: 3 days prior to Week 9 visit

    Incontinence was defined as leakage where a diaper is not used, or dampness where a diaper is used. For each one hour period of the 24 hour day, the percentage of days with incontinence was assessed as the number of days with incontinence occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  27. Percentage of Days With Incontinence for Each Hour of 24 Hour Day During Week 12

    Time frame: 3 days prior to Week 12 visit

    Incontinence was defined as leakage where a diaper is not used, or dampness where a diaper is used. For each one hour period of the 24 hour day, the percentage of days with incontinence was assessed as the number of days with incontinence occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  28. Percentage of Days With Incontinence for Each Hour of 24 Hour Day During Week 24

    Time frame: 3 days prior to Week 24 visit

    Incontinence was defined as leakage where a diaper is not used, or dampness where a diaper is used. For each one hour period of the 24 hour day, the percentage of days with incontinence was assessed as the number of days with incontinence occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  29. Percentage of Days With Incontinence for Each Hour of 24 Hour Day During Week 36

    Time frame: 3 days prior to Week 36 visit

    Incontinence was defined as leakage where a diaper is not used, or dampness where a diaper is used. For each one hour period of the 24 hour day, the percentage of days with incontinence was assessed as the number of days with incontinence occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  30. Percentage of Days With Incontinence for Each Hour of 24 Hour Day During Week 52

    Time frame: 3 days prior to Week 52 visit

    Incontinence was defined as leakage where a diaper is not used, or dampness where a diaper is used. For each one hour period of the 24 hour day, the percentage of days with incontinence was assessed as the number of days with incontinence occurring within the one hour period divided by the number of valid diary days over all participants. Each participant contributed to up to three days of valid diary data for each visit.

  31. Change From Baseline to Week 24 and 52 in Infant and Toddler Quality of Life Short Form-47 Questionnaire (ITQoL SF-47) - Overall Health Score

    Time frame: Baseline and Weeks 24, 52

    The ITQoL SF-47 consisted of 47 individual items and was filled in by the child's parent. The individual items are based on Likert scales with either 5 responses (coded as 1 through to 5) or 4 responses (coded as 1 through to 4). From subsets of these coded values, 11 scales are derived: overall health, physical activities, development, discomfort, moods and temperaments, perceptions of current past and future health and perception of changes. Each scale score ranges from 0 (worst possible) to 100 (best possible).

  32. Change From Baseline to Week 24 and 52 in ITQoL SF-47 - Physical Abilities Score

    Time frame: Baseline and Weeks 24, 52

    The ITQoL SF-47 consisted of 47 individual items and was filled in by the child's parent. The individual items are based on Likert scales with either 5 responses (coded as 1 through to 5) or 4 responses (coded as 1 through to 4). From subsets of these coded values, 11 scales are derived: overall health, physical activities, development, discomfort, moods and temperaments, perceptions of current past and future health and perception of changes. Each scale score ranges from 0 (worst possible) to 100 (best possible).

  33. Change From Baseline to Week 24 and 52 in ITQoL SF-47 - Growth and Development Score

    Time frame: Baseline and Weeks 24, 52

    The ITQoL SF-47 consisted of 47 individual items and was filled in by the child's parent. The individual items are based on Likert scales with either 5 responses (coded as 1 through to 5) or 4 responses (coded as 1 through to 4). From subsets of these coded values, 11 scales are derived: overall health, physical activities, development, discomfort, moods and temperaments, perceptions of current past and future health and perception of changes. Each scale score ranges from 0 (worst possible) to 100 (best possible).

  34. Change From Baseline to Week 24 and 52 in ITQoL SF-47 - Pain Score

    Time frame: Baseline and Weeks 24, 52

    The ITQoL SF-47 consisted of 47 individual items and was filled in by the child's parent. The individual items are based on Likert scales with either 5 responses (coded as 1 through to 5) or 4 responses (coded as 1 through to 4). From subsets of these coded values, 11 scales are derived: overall health, physical activities, development, discomfort, moods and temperaments, perceptions of current past and future health and perception of changes. Each scale score ranges from 0 (worst possible) to 100 (best possible).

  35. Change From Baseline to Week 24 and 52 in ITQoL SF-47 - Temperament and Moods Score

    Time frame: Baseline and Weeks 24, 52

    The ITQoL SF-47 consisted of 47 individual items and was filled in by the child's parent. The individual items are based on Likert scales with either 5 responses (coded as 1 through to 5) or 4 responses (coded as 1 through to 4). From subsets of these coded values, 11 scales are derived: overall health, physical activities, development, discomfort, moods and temperaments, perceptions of current past and future health and perception of changes. Each scale score ranges from 0 (worst possible) to 100 (best possible).

  36. Change From Baseline to Week 24 and 52 in ITQoL SF-47 - Behaviour Score

    Time frame: Baseline and Weeks 24, 52

    The ITQoL SF-47 consisted of 47 individual items and was filled in by the child's parent. The individual items are based on Likert scales with either 5 responses (coded as 1 through to 5) or 4 responses (coded as 1 through to 4). From subsets of these coded values, 11 scales are derived: overall health, physical activities, development, discomfort, moods and temperaments, perceptions of current past and future health and perception of changes. Each scale score ranges from 0 (worst possible) to 100 (best possible).

  37. Change From Baseline to Week 24 and 52 in ITQoL SF-47 - General Health Score

    Time frame: Baseline and Weeks 24, 52

    The ITQoL SF-47 consisted of 47 individual items and was filled in by the child's parent. The individual items are based on Likert scales with either 5 responses (coded as 1 through to 5) or 4 responses (coded as 1 through to 4). From subsets of these coded values, 11 scales are derived: overall health, physical activities, development, discomfort, moods and temperaments, perceptions of current past and future health and perception of changes. Each scale score ranges from 0 (worst possible) to 100 (best possible).

  38. Change From Baseline to Week 24 and 52 in ITQoL SF-47 - Change in Health Score

    Time frame: Baseline and Weeks 24, 52

    The ITQoL SF-47 consisted of 47 individual items and was filled in by the child's parent. The individual items are based on Likert scales with either 5 responses (coded as 1 through to 5) or 4 responses (coded as 1 through to 4). From subsets of these coded values, 11 scales are derived: overall health, physical activities, development, discomfort, moods and temperaments, perceptions of current past and future health and perception of changes. Each scale score ranges from 0 (worst possible) to 100 (best possible).

  39. Change From Baseline to Week 24 and 52 in ITQoL SF-47 - Parent-Emotional Impact Score

    Time frame: Baseline and Weeks 24, 52

    The ITQoL SF-47 consisted of 47 individual items and was filled in by the child's parent. The individual items are based on Likert scales with either 5 responses (coded as 1 through to 5) or 4 responses (coded as 1 through to 4). From subsets of these coded values, 11 scales are derived: overall health, physical activities, development, discomfort, moods and temperaments, perceptions of current past and future health and perception of changes. Each scale score ranges from 0 (worst possible) to 100 (best possible).

  40. Change From Baseline to Week 24 and 52 in ITQoL SF-47 - Parent-Time Impact Score

    Time frame: Baseline and Weeks 24, 52

    The ITQoL SF-47 consisted of 47 individual items and was filled in by the child's parent. The individual items are based on Likert scales with either 5 responses (coded as 1 through to 5) or 4 responses (coded as 1 through to 4). From subsets of these coded values, 11 scales are derived: overall health, physical activities, development, discomfort, moods and temperaments, perceptions of current past and future health and perception of changes. Each scale score ranges from 0 (worst possible) to 100 (best possible).

  41. Change From Baseline to Week 24 and 52 in ITQoL SF-47 - Family Cohesion Impact Score

    Time frame: Baseline and Weeks 24, 52

    The ITQoL SF-47 consisted of 47 individual items and was filled in by the child's parent. The individual items are based on Likert scales with either 5 responses (coded as 1 through to 5) or 4 responses (coded as 1 through to 4). From subsets of these coded values, 11 scales are derived: overall health, physical activities, development, discomfort, moods and temperaments, perceptions of current past and future health and perception of changes. Each scale score ranges from 0 (worst possible) to 100 (best possible).

Sponsors and collaborators

Lead sponsor

Astellas Pharma Europe B.V.

Industry

Registry information

Official study title

A Phase 3, Open-Label, Baseline-controlled, Multi-center, Sequential Dose-Titration Study to Assess the Pharmacokinetics, Long-Term Efficacy and Safety of Solifenacin Succinate Suspension in Children From 6 Months to Less Than 5 Years of Age With Neurogenic Detrusor Overactivity

Important dates

Study start
2013
Primary completion
2015
Study completion
2015
First posted
Nov 13, 2013
Registry last updated
Oct 31, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.